VolitionRx Limited Schedules Third Quarter 2023 Earnings Conference Call and Business Update
- None.
- None.
Conference call to take place on Wednesday November 15 at 8:30 a.m.
Event: VolitionRx Limited Third Quarter 2023 Earnings and Business Update Conference Call
Date: Wednesday, November 15, 2023
Time: 8:30 a.m.
Toll/International: 1-201-493-6779
Conference ID: 13742634
Cameron Reynolds, President and Group Chief Executive Officer of Volition, will host the call along with Terig Hughes, Group Chief Financial Officer, Dr. Tom Butera, Chief Executive Officer of Volition Veterinary Diagnostics Development LLC, Dr. Andrew Retter, Medical Consultant to Volition and Scott Powell, Executive Vice President, Investor Relations. The call will provide an update on important events which have taken place in the third quarter of 2023 and upcoming milestones.
A live audio webcast of the conference call will also be available on the investor relations page of Volition's corporate website at https://ir.volition.com. In addition, a telephone replay of the call will be available until November 29, 2023. The replay dial-in numbers are 1-844-512-2921 (toll-free) in the
About Volition
Volition is a multi-national epigenetics company focused on advancing the science of epigenetics. Volition is dedicated to saving lives and improving outcomes for people and animals with life-altering diseases through earlier detection, disease and treatment monitoring.
Through its subsidiaries, Volition is developing and commercializing simple, easy to use, cost-effective blood tests to help diagnose and monitor a range of diseases, including some cancers and diseases associated with NETosis, such as sepsis. Early diagnosis and monitoring have the potential to not only prolong the life of patients, but also improve their quality of life.
Volition's research and development activities are centered in
The contents found at Volition's website address are not incorporated by reference into this document and should not be considered part of this document. Such website address is included in this document as an inactive textual reference only.
Media Enquiries:
Louise Batchelor/Debra Daglish, Volition, mediarelations@volition.com +44 (0)7557 774620
View original content:https://www.prnewswire.com/news-releases/volitionrx-limited-schedules-third-quarter-2023-earnings-conference-call-and-business-update-301981625.html
SOURCE VolitionRx Limited
FAQ
What is the purpose of VolitionRx Limited's conference call on November 15?
Who will be hosting the conference call for VolitionRx Limited?
Where can I find the live audio webcast of the conference call?